The platform OncoBeamTM, using BEAMing (beads, emulsification, amplification, and magnetics), offers panels for the detection of various CRC specific mutations, including KRAS, NRAS, BRAF, and PIK3CA [155]. Here, KRAS is linked to colorectal carcinoma.